BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32729451)

  • 1. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
    Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
    Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Ghosh AP; Aycock C; Schwebke JR
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439963
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Mtshali A; Ngcapu S; Govender K; Sturm AW; Moodley P; Joubert BC
    Microbiol Spectr; 2022 Aug; 10(4):e0091222. PubMed ID: 35863010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil.
    da Luz Becker D; dos Santos O; Frasson AP; de Vargas Rigo G; Macedo AJ; Tasca T
    Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure.
    Augostini P; Bradley ELP; Raphael BH; Secor WE
    Sex Transm Dis; 2023 Jun; 50(6):370-373. PubMed ID: 36849257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between Mycoplasma hominis and Trichomonas vaginalis symbiosis in relation to metronidazole resistance.
    Mabaso N; Tinarwo P; Abbai N
    Parasitol Res; 2020 Dec; 119(12):4197-4204. PubMed ID: 33068149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycoplasma hominis impacts gene expression in Trichomonas vaginalis.
    Fürnkranz U; Henrich B; Walochnik J
    Parasitol Res; 2018 Mar; 117(3):841-847. PubMed ID: 29368037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of double-stranded RNA virus in Trichomonas vaginalis isolated in Italy and association with the symbiont Mycoplasma hominis.
    Margarita V; Marongiu A; Diaz N; Dessì D; Fiori PL; Rappelli P
    Parasitol Res; 2019 Dec; 118(12):3565-3570. PubMed ID: 31701295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Indicators of Drug Resistance in the Highly Repetitive Genome of Trichomonas vaginalis.
    Bradic M; Warring SD; Tooley GE; Scheid P; Secor WE; Land KM; Huang PJ; Chen TW; Lee CC; Tang P; Sullivan SA; Carlton JM
    Genome Biol Evol; 2017 Jun; 9(6):1658-1672. PubMed ID: 28633446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic signatures of metronidazole-resistant Trichomonas vaginalis reveal novel proteins associated with drug resistance.
    Lin HC; Chu LJ; Huang PJ; Cheng WH; Zheng YH; Huang CY; Hong SW; Chen LC; Lin HA; Wang JY; Chen RM; Lin WN; Tang P; Huang KY
    Parasit Vectors; 2020 Jun; 13(1):274. PubMed ID: 32487244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
    Forbes GL; Drayton R; Forbes GD
    Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase solubility studies and anti-Trichomonas vaginalis activity evaluations of metronidazole and methylated β-cyclodextrin complexes: Comparison of CRYSMEB and RAMEB.
    Malli S; Bories C; Ponchel G; Loiseau PM; Bouchemal K
    Exp Parasitol; 2018 Jun; 189():72-75. PubMed ID: 29730454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of amixicile against T. vaginalis from clinical isolates.
    Jain E; Zaenker EI; Hoffman PS; Warren CA
    Parasitol Res; 2022 Aug; 121(8):2453-2455. PubMed ID: 35676563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effect of manuka honey on anaerobic parasitic protozoans with standard drug therapy under
    Sinha S; Prakash A; Sehgal R; Medhi B
    Indian J Pharmacol; 2018; 50(4):197-203. PubMed ID: 30505056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HQSAR and random forest-based QSAR models for anti-T. vaginalis activities of nitroimidazoles derivatives.
    Veríssimo GC; Menezes Dutra EF; Teotonio Dias AL; de Oliveira Fernandes P; Kronenberger T; Gomes MA; Maltarollo VG
    J Mol Graph Model; 2019 Jul; 90():180-191. PubMed ID: 31100677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.
    Cudmore SL; Delgaty KL; Hayward-McClelland SF; Petrin DP; Garber GE
    Clin Microbiol Rev; 2004 Oct; 17(4):783-93, table of contents. PubMed ID: 15489348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antimicrobial peptides LL-37, KR-20, FK-13 and KR-12 inhibit the growth of a sensitive and a metronidazole-resistant strain of Trichomonas vaginalis.
    Ramírez-Ledesma MG; Rodríguez MC; Alva-Murillo N; Avila EE
    Parasitol Res; 2022 Dec; 121(12):3503-3512. PubMed ID: 36171407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.
    Meingassner JG; Thurner J
    Antimicrob Agents Chemother; 1979 Feb; 15(2):254-7. PubMed ID: 311617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis.
    Küng E; Pietrzak J; Klaus C; Walochnik J
    Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.